Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study

ConclusionEarly therapeutic drug monitoring might improve timely detection of vedolizumab‐treated patients in need for an intensified dosing regimen.

Source: Alimentary Pharmacology and Therapeutics - January 31, 2018 Category: Drugs & Pharmacology Authors: W. Yacoub, N. Williet, L. Pouillon, T. Di ‐Bernado, M. De Carvalho Bittencourt, S. Nancey, A. Lopez, S. Paul, C. Zallot, X. Roblin, L. Peyrin‐Biroulet Tags: Original Article Source Type: research